P DAngelo
Overview
Explore the profile of P DAngelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bassato F, Mauri S, Braglia L, Petrov A, Dobovicnik E, Tavani F, et al.
J Phys Chem Lett
. 2024 Aug;
15(33):8540-8548.
PMID: 39136616
A-site doped SrTiO is considered as a promising substitute for traditional anodic metals in solid oxide fuel cells (SOFCs). In this study, we present the reactivity of LaSrCaTiO (LCSTO), LaSrTiO...
2.
Potvin D, DAngelo P, Bennett S, Jankicevic J, Bissonnette R
J Eur Acad Dermatol Venereol
. 2024 Apr;
38(9):1694-1703.
PMID: 38619384
Current drug development strategies present many challenges that can impede drug approval by regulatory agencies. Alternative study models, such as adaptive trial designs, have recently sparked interest, as they provide...
3.
Bissonnette R, Eichenfield L, Simpson E, Thaci D, Kabashima K, Thyssen J, et al.
J Eur Acad Dermatol Venereol
. 2023 Jan;
37(5):976-983.
PMID: 36652273
Despite the emergence of novel targeted treatments for atopic dermatitis (AD), there is a lack of guidelines on standardizing analysis of clinical trial data. To define and estimate meaningful treatment...
4.
Fornara C, Zavaglio F, Furione M, Sarasini A, DAngelo P, Arossa A, et al.
Med Microbiol Immunol
. 2022 Aug;
211(5-6):249-260.
PMID: 35960328
Human cytomegalovirus (HCMV) shedding has been extensively investigated in newborns and in young children, however, much less is known about it in immunocompetent adults. Shedding of HCMV was investigated in...
5.
Ghigna P, Airoldi L, Fracchia M, Callegari D, Anselmi-Tamburini U, DAngelo P, et al.
ACS Appl Mater Interfaces
. 2020 Oct;
12(45):50344-50354.
PMID: 33124794
High-entropy oxides based on transition metals, such as MgCoNiCuZnO (TM-HEO), have recently drawn special attention as potential anodes in lithium-ion batteries due to high specific capacity and cycling reversibility. However,...
6.
Tarabella G, DAngelo P, Cifarelli A, Dimonte A, Romeo A, Berzina T, et al.
Chem Sci
. 2017 Jul;
6(5):2859-2868.
PMID: 28706673
A hybrid bio-organic electrochemical transistor was developed by interfacing an organic semiconductor, poly(3,4-ethylenedioxythiophene) doped with poly(styrene sulfonate), with the cell. The system shows unprecedented performances since it could be operated...
7.
Terenziani M, Bisogno G, Boldrini R, Cecchetto G, Conte M, Boschetti L, et al.
Pediatr Blood Cancer
. 2017 Apr;
64(11).
PMID: 28449306
Objective: Malignant ovarian germ cell tumors (MOGCT) carry an excellent prognosis, and the treatment aims to achieve results with the least possible treatment-related morbidity. The aim of this study was...
8.
Cereser L, Girometti R, DAngelo P, De Carli M, De Pellegrin A, Zuiani C
Clin Radiol
. 2017 Apr;
72(7):534-542.
PMID: 28433201
Humoral primary immunodeficiency diseases (hPIDs) are a heterogeneous group of hereditary disorders resulting in abnormal susceptibility to infections of the sinopulmonary tract. Some of these conditions (e.g., common variable immunodeficiency...
9.
Rovelli A, DAngelo P, Balduzzi A, Borzini P, Biondi A, Uderzo C
Leuk Lymphoma
. 2016 Jul;
5(1):71-4.
PMID: 27463212
A 12-year-old boy developed persistent thrombocytopenia after undergoing bone marrow transplantation for acute myelogenous leukemia. High doses of intravenous immunoglobulins were used to treat overt hemorrhage and a sudden intravascular...
10.
Di Cataldo A, Agodi A, Balaguer J, Garaventa A, Barchitta M, Segura V, et al.
Clin Transl Oncol
. 2016 Apr;
19(1):76-83.
PMID: 27041689
Introduction: SIOPEN INES protocol yielded excellent 5-year survival rates for MYCN-non-amplified metastatic neuroblastoma. Patients deemed ineligible due to lack or delay of MYCN status or late registration were treated, but...